Patient Recall of Cancer Screening and Diagnosis

Breast Cancer Clinical Trial

Official title:

Patient Recall of Cancer Screening and Diagnosis

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05014295
• Other study ID #: CASE1Z21
• Status: Recruiting
• Phase: N/A
• Start date: April 30, 2024
• Est. completion date: June 2025

Study information

• Verified date: October 2023
• Source: Case Comprehensive Cancer Center
• Contact: Cheryl Thompson, PhD
• Phone: 216-368-3956
• Email: clw8[@]case.edu
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this research is to try to better understand how much information relating to cancer screening and diagnoses that people can recall on their own and to better understand how to help people get better information. In this study, investigators will see if giving time or other resources help individuals remember more and more accurate details about their cancer screening and care.

Description:

This is a randomized controlled trial of an intervention to encourage use of online medical records for filling out a cancer screening, diagnosis and treatment questionnaire. Participants will be asked to self-report on cancer screening and treatment. They will then be asked the same questions again a week later. The control group will have had one week to reflect on the questions, and investigators anticipate some influence of this on responses. The intervention group will be prompted about accessing their medical records from the major local health systems online, with links to directions provided by each hospital system. They will then be asked to fill out the same questionnaire.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 100
• Est. completion date: June 2025
• Est. primary completion date: December 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• diagnosed with breast or prostate cancer within the last 10 years
• have access to the internet with a working email address
• reside in Northeast Ohio Exclusion Criteria: -

Related Conditions & MeSH terms

• Breast Cancer
• Prostate Cancer
• Prostatic Neoplasms

Intervention

Other:
• Accessing personal medical records online via online portals
The participants will receive details on accessing personal medical records online via online portals, for each of the major hospital systems

Locations

Country	Name	City	State
United States	Case Comprehensive Cancer Center	Cleveland	Ohio

Sponsors (1)

Lead Sponsor	Collaborator
Case Comprehensive Cancer Center

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Completeness of survey	Completeness: For each survey, for each participant, investigators will count the number of "don't know" response rates. From this, investigators will calculate the percent completeness of the survey.	at 1 week (after second survey completed)
Primary	Accuracy of survey	Investigators will assess the inter-rater reliability between the first and second survey by calculating a Cohen's Kappa coefficient. Although not a perfect assumption, investigators will use the second survey as the reference. Number of changed answers on an individual level will be calculated, representing improved accuracy. Investigators do not anticipate many changes, and, again, this will not be normally distributed.	at 1 week (after second survey completed)